{
  "id": 1643,
  "text": "98 (95% CI = 0.70-1.38)</td></tr><tr><td>Rose et al.1437</td><td>2007</td><td>CCRT (hydroxyurea)</td><td>CCRT (cisplatin + 5 fluorouracil + hydroxyurea)</td><td>OR = 0.65 (95% CI= 0.45-0.94)</td></tr><tr><td> 5-year DFS rate</td><td></td><td></td><td></td><td></td></tr><tr><td>Zuliani et al.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: 98 (95% CI = 0.70-1.38)</td></tr><tr><td>Rose et al.1437</td><td>2007</td><td>CCRT (hydroxyurea)</td><td>CCRT (cisplatin + 5 fluorouracil + hydroxyurea)</td><td>OR = 0.65 (95% CI= 0.45-0.94)</td></tr><tr><td> 5-year DFS rate</td><td></td><td></td><td></td><td></td></tr><tr><td>Zuliani et al.\n\n<question>: ",
  "ChatGPT_response_0": "根据98个病例的研究结果和95%的可信区间0.65 (95% CI = 0.45-0.94)，显示氢基脲（CCRT）和顺铂+5氟尿嘧啶+氢基脲（CCRT）在5年DFS率方面存在一定差异。然而，要确定这两种方案是否有显著差异，还需要进一步进行更多研究和综合分析，以获取更准确的结论。",
  "query": "针对CCRT（氢基脲）和CCRT（顺铂+5氟尿嘧啶+氢基脲），结合98个病例的OR值结果和95%的可信区间0.65 (95% CI = 0.45-0.94)，请问您认为这两种方案在5年DFS率方面是否有显著差异？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 针对CCRT（氢基脲）和CCRT（顺铂+5氟尿嘧啶+氢基脲），结合98个病例的OR值结果和95%的可信区间0.65 (95% CI = 0.45-0.94)，请问您认为这两种方案在5年DFS率方面是否有显著差异？\n\n<reference text>: 98 (95% CI = 0.70-1.38)</td></tr><tr><td>Rose et al.1437</td><td>2007</td><td>CCRT (hydroxyurea)</td><td>CCRT (cisplatin + 5 fluorouracil + hydroxyurea)</td><td>OR = 0.65 (95% CI= 0.45-0.94)</td></tr><tr><td> 5-year DFS rate</td><td></td><td></td><td></td><td></td></tr><tr><td>Zuliani et al.\n\n<reply>: ",
  "response": "根据98个病例的研究结果和95%的可信区间0.65 (95% CI = 0.45-0.94)，显示氢基脲（CCRT）和顺铂+5氟尿嘧啶+氢基脲（CCRT）在5年DFS率方面存在一定差异。然而，要确定这两种方案是否有显著差异，还需要进一步进行更多研究和综合分析，以获取更准确的结论。"
}